We have located links that may give you full text access.
Comparing outcomes of trabeculectomy with mitomycin C to 45 μm gelatin stent placed ab externo with open conjunctiva.
Ophthalmology Glaucoma 2023 December 5
PURPOSE: To compare trabeculectomy with mitomycin C (trab-MMC) and XEN®45 Gel Stent placed ab externo with open conjunctiva (XGS AEO) with or without cataract surgery in patients with glaucoma.
DESIGN: Nonrandomized, retrospective comparative study.
SUBJECTS: A total of 204 eyes from 204 glaucoma patients who received XGS placed AEO or underwent trab-MMC with or without cataract surgery between July 2018 and August 2021 at Massachusetts Eye and Ear.
METHODS: Visits from 204 patients' charts were reviewed following either trab-MMC or XGS AEO from 2018-2021 from a level 3 triage center.
MAIN OUTCOME MEASURES: Intraocular pressure (IOP), medication burden, Kaplan-Meier success rates, 5-fluorouracil impact, and complications.
RESULTS: 157 patients underwent trab-MMC and 47 underwent XGS AEO. Groups had similar baseline intraocular pressure (IOP) and medications (meds). IOP and meds decreased similarly at 1.5 years (11.2 mmHg vs 7.4 mmHg, p=0.62; 2.9 vs 2.8 meds, p=0.92, respectively for trab-MMC and XGS AEO). Success was defined as IOP reduction ≥ 20% with 5 mmHg ≤ IOP ≤ 18 mmHg for 2 consecutive visits. Complete success (CS) did not allow meds; qualified success (QS) allowed for ≤ baseline meds. When IOP fluctuations in the first 60 days were not counted as failures, CS was 43% for trab-MMC, about 8.5% higher than for XGS AEO (p<0.01). QS was similar between the groups (65-67%). Procedure time was shorter for XGS AEO than trab-MMC (44 vs 63 min, p<0.01).
CONCLUSIONS: XGS AEO may provide similar benefits to trab-MMC, especially for patients who tolerate some meds, with shorter procedure times.
DESIGN: Nonrandomized, retrospective comparative study.
SUBJECTS: A total of 204 eyes from 204 glaucoma patients who received XGS placed AEO or underwent trab-MMC with or without cataract surgery between July 2018 and August 2021 at Massachusetts Eye and Ear.
METHODS: Visits from 204 patients' charts were reviewed following either trab-MMC or XGS AEO from 2018-2021 from a level 3 triage center.
MAIN OUTCOME MEASURES: Intraocular pressure (IOP), medication burden, Kaplan-Meier success rates, 5-fluorouracil impact, and complications.
RESULTS: 157 patients underwent trab-MMC and 47 underwent XGS AEO. Groups had similar baseline intraocular pressure (IOP) and medications (meds). IOP and meds decreased similarly at 1.5 years (11.2 mmHg vs 7.4 mmHg, p=0.62; 2.9 vs 2.8 meds, p=0.92, respectively for trab-MMC and XGS AEO). Success was defined as IOP reduction ≥ 20% with 5 mmHg ≤ IOP ≤ 18 mmHg for 2 consecutive visits. Complete success (CS) did not allow meds; qualified success (QS) allowed for ≤ baseline meds. When IOP fluctuations in the first 60 days were not counted as failures, CS was 43% for trab-MMC, about 8.5% higher than for XGS AEO (p<0.01). QS was similar between the groups (65-67%). Procedure time was shorter for XGS AEO than trab-MMC (44 vs 63 min, p<0.01).
CONCLUSIONS: XGS AEO may provide similar benefits to trab-MMC, especially for patients who tolerate some meds, with shorter procedure times.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app